Characteristics and Outcomes of Latinx Patients With COVID-19 in Comparison With Other Ethnic and Racial Groups.
COVID-19
SARS-CoV-2
disparities
ethnicity
hospitalizations
race
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
03
08
2020
accepted:
26
08
2020
entrez:
22
10
2020
pubmed:
23
10
2020
medline:
23
10
2020
Statut:
epublish
Résumé
There is a limited understanding of the impact of coronavirus disease 2019 (COVID-19) on the Latinx population. We hypothesized that Latinx patients would be more likely to be hospitalized and admitted to the intensive care unit (ICU) than White patients. We analyzed all patients with COVID-19 in 12 Massachusetts hospitals between February 1 and April 14, 2020. We examined the association between race, ethnicity, age, reported comorbidities, and hospitalization and ICU admission using multivariable regression. Of 5190 COVID-19 patients, 29% were hospitalized; 33% required the ICU, and 4.3% died. Forty-six percent of patients were White, 25% Latinx, 14% African American, and 3% Asian American. Ethnicity and race were significantly associated with hospitalization. More Latinx and African American patients in the younger age groups were hospitalized than whites. Latinxs and African Americans disproportionally required the ICU, with 39% of hospitalized Latinx patients requiring the ICU compared with 33% of African Americans, 24% of Asian Americans, and 30% of Whites ( Latinx and African American patients with COVID-19 have higher rates of hospitalization and ICU admission than White patients. The etiologies of such disparities are likely multifactorial and cannot be explained only by reported comorbidities.
Sections du résumé
BACKGROUND
BACKGROUND
There is a limited understanding of the impact of coronavirus disease 2019 (COVID-19) on the Latinx population. We hypothesized that Latinx patients would be more likely to be hospitalized and admitted to the intensive care unit (ICU) than White patients.
METHODS
METHODS
We analyzed all patients with COVID-19 in 12 Massachusetts hospitals between February 1 and April 14, 2020. We examined the association between race, ethnicity, age, reported comorbidities, and hospitalization and ICU admission using multivariable regression.
RESULTS
RESULTS
Of 5190 COVID-19 patients, 29% were hospitalized; 33% required the ICU, and 4.3% died. Forty-six percent of patients were White, 25% Latinx, 14% African American, and 3% Asian American. Ethnicity and race were significantly associated with hospitalization. More Latinx and African American patients in the younger age groups were hospitalized than whites. Latinxs and African Americans disproportionally required the ICU, with 39% of hospitalized Latinx patients requiring the ICU compared with 33% of African Americans, 24% of Asian Americans, and 30% of Whites (
CONCLUSIONS
CONCLUSIONS
Latinx and African American patients with COVID-19 have higher rates of hospitalization and ICU admission than White patients. The etiologies of such disparities are likely multifactorial and cannot be explained only by reported comorbidities.
Identifiants
pubmed: 33088846
doi: 10.1093/ofid/ofaa401
pii: ofaa401
pmc: PMC7499713
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa401Subventions
Organisme : NIAID NIH HHS
ID : U01 AI136816
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
J Gen Intern Med. 2014 Apr;29(4):602-7
pubmed: 24366395
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Value Health. 2014 Mar;17(2):288-96
pubmed: 24636389
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):655-659
pubmed: 32438328
J Natl Med Assoc. 2012 Jan-Feb;104(1-2):89-95
pubmed: 22708252
N Engl J Med. 2020 Jul 9;383(2):e5
pubmed: 32374957
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
PLoS One. 2019 Feb 14;14(2):e0212117
pubmed: 30763400
N Engl J Med. 2020 Jul 16;383(3):201-203
pubmed: 32374952
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
JAMA. 2020 Apr 14;323(14):1335
pubmed: 32181795
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057
pubmed: 32267833
Lancet Infect Dis. 2020 Sep;20(9):1034-1042
pubmed: 32422204
J Racial Ethn Health Disparities. 2020 Feb;7(1):1-9
pubmed: 31410785
Lancet Public Health. 2020 May;5(5):e251-e252
pubmed: 32199083
Arch Intern Med. 2007 Sep 24;167(17):1853-60
pubmed: 17893306
N Engl J Med. 2002 Nov 14;347(20):1585-92
pubmed: 12432046
Metabolism. 2020 Jul;108:154251
pubmed: 32353356
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Popul Dev Rev. 2009 Mar;35(1):1-51
pubmed: 20539823
N Engl J Med. 1998 Jan 15;338(3):171-9
pubmed: 9428819
Am J Public Health. 2010 Apr 1;100 Suppl 1:S186-96
pubmed: 20147693
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Am Coll Cardiol. 2020 Jun 2;75(21):2746-2748
pubmed: 32330545
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864